MiNK Therapeutics, Inc. (INKT)
(Delayed Data from NSDQ)
$15.09 USD
-0.26 (-1.69%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $15.08 -0.01 (-0.07%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth F Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
MiNK Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
INKT 15.09 -0.26(-1.69%)
Will INKT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for INKT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INKT
New Strong Sell Stocks for August 22nd
INKT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for INKT
Is INKT poised for gains? 20 Day Moving Average Support shows up after sliding 1.69%
Crossed Above 20 Day Moving Average appears for INKT after 7.79% move
Is INKT showing downside potential? 20 Day Moving Average Resistance shows up after sliding 2.4%
MiNK Therapeutics appoints Hammond as Head of Inflammatory, Pulmonary Diseases
MiNK Therapeutics appoints Hammond as Head of Inflammatory, Pulmonary Diseases